Atossa Genetics (ATOS) SEC Filings & 10K Form $0.94 0.00 (-0.20%) Closing price 04:00 PM EasternExtended Trading$0.92 -0.01 (-1.45%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Atossa Genetics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel DateFilerForm TypeView05/22/20255:27 PMAtossa Genetics (Issuer)QUAY STEVEN C (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20257:05 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/13/20257:15 AMAtossa Genetics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 03/26/20253:40 PMAtossa Genetics (Filer)Form ARS03/26/20253:30 PMAtossa Genetics (Filer)Form DEF 14A03/25/20257:05 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/25/20257:10 AMAtossa Genetics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/12/20258:00 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/24/20253:05 PMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/07/20253:09 PMAtossa Genetics (Subject)CVI Investments, Inc. (Filed by)Form SCHEDULE 13G/A02/04/20258:00 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/10/20248:05 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/12/202412:32 PMAtossa Genetics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/202410:27 AMAtossa Genetics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/20245:35 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/22/20242:24 PMAtossa Genetics (Subject)BlackRock, Inc. (Filed by)Form SC 13G08/12/20248:00 AMAtossa Genetics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/12/20248:05 AMAtossa Genetics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PureTech Health 10Q Form MBX Biosciences 10Q Form Rezolute 10Q Form REGENXBIO 10Q Form Tourmaline Bio 10Q Form Savara 10Q Form Erasca 10Q Form Tectonic Therapeutic 10Q Form Eton Pharmaceuticals 10Q Form iTeos Therapeutics 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ATOS) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored“The Best Gold Investment You’ve Never Heard Of”Gold may be surging past $3,500 — but one rare class of stocks is leaving bullion in the dust. Gold royalti...Golden Portfolio | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Genetics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATOS Stock Alerts